BillionToOne stock jumps after fresh 2026 revenue outlook signals faster growth
BillionToOne shares rose about 7% to $92.20 midday after the company issued its first full-year 2026 revenue forecast, projecting $415 million to $430 million and positive GAAP operating income. The diagnostics firm reaffirmed its 2025 revenue outlook. Investors are seeking more details from its J.P. Morgan Healthcare Conference materials.
